Business Context and Reporting Period
Company: CODEXIS, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: April 5, 2018 (Event Date)
Reporting Period: The filing covers a capital raising event initiated on April 5, 2018, and closed on April 10, 2018.
Key Financial Metrics
This filing details a secondary offering of common stock rather than operational financial results. Key metrics related to the transaction include:
- Shares Issued: 4,312,500 shares of Common Stock (3,750,000 initial shares plus 562,500 additional shares from the full exercise of the underwriters' option).
- Offering Price: $9.25 per share.
- Net Proceeds: Approximately $37.2 million (after deducting underwriters' discounts, commissions, and estimated offering expenses).
- Underwriters: Jefferies LLC and Cowen and Company, LLC.
Note: The filing text does not provide values for revenue, profit, cash flow, margins, or existing debt levels.
Material Changes
The primary material change is the increase in the company's share count and cash liquidity resulting from the public offering. The company completed the sale and issuance of an aggregate of 4,312,500 shares of Common Stock, raising approximately $37.2 million in net proceeds.
Guidance, Outlook, and Contingencies
Lock-Up Agreement: The Company, its directors, and executive officers agreed not to sell or transfer any Common Stock held by them for 90 days following April 5, 2018, without the written consent of the underwriters' representatives.
Indemnification: The Company agreed to indemnify the underwriters against certain liabilities under the Securities Act of 1933 or contribute to payments required by the underwriters.
Outlook: The filing text does not provide specific forward-looking guidance, management commentary on future operations, or discussion of risks beyond the standard indemnification and lock-up terms.
Investor Verification Checklist
- Verify the final net proceeds of $37.2 million against the total shares issued (4,312,500) and the offering price ($9.25) to confirm the deduction of underwriting fees and expenses.
- Confirm the dilution impact of the 4,312,500 new shares on existing shareholders.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific details on the indemnification clauses and exceptions to the 90-day lock-up period.
- Check subsequent filings to determine how the $37.2 million in proceeds is being utilized (e.g., R&D, debt repayment, general corporate purposes).